More recently, biologic therapies such as tumor necrosis factor (TNF) inhibitors have been added to the treatment armamentarium with dramatic improvement in both the signs and symptoms of JIA as well as outcomes [4-9]. Here, TNF is linked to juvenile idiopathic arthritis.